S&P 500   4,267.92 (-0.13%)
DOW   33,520.04 (-0.29%)
QQQ   352.16 (-0.58%)
AAPL   169.25 (-1.58%)
MSFT   310.16 (-0.63%)
META   290.34 (-2.88%)
GOOGL   129.10 (+0.41%)
AMZN   124.95 (-0.82%)
TSLA   236.60 (-3.08%)
NVDA   419.62 (+0.12%)
NIO   8.42 (+0.12%)
BABA   85.67 (-0.28%)
AMD   97.20 (+1.29%)
T   14.84 (-1.20%)
F   12.31 (-0.97%)
MU   67.32 (-0.91%)
CGC   0.90 (-1.88%)
GE   110.23 (+0.27%)
DIS   79.56 (-0.61%)
AMC   7.63 (-3.54%)
PFE   32.04 (-1.11%)
PYPL   56.89 (-3.46%)
NFLX   377.61 (-0.43%)
S&P 500   4,267.92 (-0.13%)
DOW   33,520.04 (-0.29%)
QQQ   352.16 (-0.58%)
AAPL   169.25 (-1.58%)
MSFT   310.16 (-0.63%)
META   290.34 (-2.88%)
GOOGL   129.10 (+0.41%)
AMZN   124.95 (-0.82%)
TSLA   236.60 (-3.08%)
NVDA   419.62 (+0.12%)
NIO   8.42 (+0.12%)
BABA   85.67 (-0.28%)
AMD   97.20 (+1.29%)
T   14.84 (-1.20%)
F   12.31 (-0.97%)
MU   67.32 (-0.91%)
CGC   0.90 (-1.88%)
GE   110.23 (+0.27%)
DIS   79.56 (-0.61%)
AMC   7.63 (-3.54%)
PFE   32.04 (-1.11%)
PYPL   56.89 (-3.46%)
NFLX   377.61 (-0.43%)
S&P 500   4,267.92 (-0.13%)
DOW   33,520.04 (-0.29%)
QQQ   352.16 (-0.58%)
AAPL   169.25 (-1.58%)
MSFT   310.16 (-0.63%)
META   290.34 (-2.88%)
GOOGL   129.10 (+0.41%)
AMZN   124.95 (-0.82%)
TSLA   236.60 (-3.08%)
NVDA   419.62 (+0.12%)
NIO   8.42 (+0.12%)
BABA   85.67 (-0.28%)
AMD   97.20 (+1.29%)
T   14.84 (-1.20%)
F   12.31 (-0.97%)
MU   67.32 (-0.91%)
CGC   0.90 (-1.88%)
GE   110.23 (+0.27%)
DIS   79.56 (-0.61%)
AMC   7.63 (-3.54%)
PFE   32.04 (-1.11%)
PYPL   56.89 (-3.46%)
NFLX   377.61 (-0.43%)
S&P 500   4,267.92 (-0.13%)
DOW   33,520.04 (-0.29%)
QQQ   352.16 (-0.58%)
AAPL   169.25 (-1.58%)
MSFT   310.16 (-0.63%)
META   290.34 (-2.88%)
GOOGL   129.10 (+0.41%)
AMZN   124.95 (-0.82%)
TSLA   236.60 (-3.08%)
NVDA   419.62 (+0.12%)
NIO   8.42 (+0.12%)
BABA   85.67 (-0.28%)
AMD   97.20 (+1.29%)
T   14.84 (-1.20%)
F   12.31 (-0.97%)
MU   67.32 (-0.91%)
CGC   0.90 (-1.88%)
GE   110.23 (+0.27%)
DIS   79.56 (-0.61%)
AMC   7.63 (-3.54%)
PFE   32.04 (-1.11%)
PYPL   56.89 (-3.46%)
NFLX   377.61 (-0.43%)
NASDAQ:HSAQ

Health Sciences Acquisitions Co. 2 (HSAQ) Stock Forecast, Price & News

$7.89
-0.60 (-7.07%)
(As of 09/26/2023 ET)
Compare
Today's Range
$7.88
▼
$8.70
50-Day Range
$5.08
▼
$13.31
52-Week Range
$9.41
▼
$13.80
Volume
84,024 shs
Average Volume
205,918 shs
Market Capitalization
$88.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

HSAQ stock logo

About Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) Stock

Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.

HSAQ Price History

HSAQ Stock News Headlines

August 16, 2023 | axios.com
JPMorgan, Oppenheimer advising Cano Health
August 7, 2023 | latimes.com
NIH ices research on health communication and misinformation. Is it self-censorship?
September 27, 2023 | Wall Street Fundamentals (Ad)
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
April 13, 2023 | bizjournals.com
Healthcare and life sciences industry leaders optimistic despite historic upheavals and great uncertainty
April 11, 2023 | markets.businessinsider.com
DISCOVERY LIFE SCIENCES ACQUIRES REACHBIO RESEARCH LABS
January 27, 2023 | finance.yahoo.com
Orchestra BioMed Debuts as Nasdaq-Traded Company with Lead Programs Targeting Hypertension and Artery Disease and Novel Partnership-Enabled Business Model
January 24, 2023 | usnews.com
What You Need to Know About Becoming a Health Science Major
January 6, 2023 | finance.yahoo.com
Health Sciences Acquisitions Corporation 2 (HSAQ)
September 27, 2023 | Wall Street Fundamentals (Ad)
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
September 20, 2022 | finance.yahoo.com
Orchestra BioMed™ Announces Presentation of Positive Long-Term Clinical Results from MODERATO II Control Patients Crossover Extension Study of BackBeat CNT™ at TCT 2022
September 16, 2022 | msn.com
From sports tech to health care, Boston is exporting innovation
September 16, 2022 | forbes.com
Addressing The Disconnect Between American Healthcare And Modern Society
September 13, 2022 | msn.com
Free preventive care under the ACA is under threat again – a ruling exempting PrEP from insurance coverage may extend nationwide and to other health services
September 13, 2022 | msn.com
AnPac Bio-Medical Sciences faces possible stock exchange delisting due to stock price
September 13, 2022 | finance.yahoo.com
Numinus provides update on acquisition integration and announces new client financing options
September 13, 2022 | finance.yahoo.com
New Research from the Clarify Health Institute Highlights the Severity of Pediatric Mental Health Conditions in the United States
September 12, 2022 | news.yahoo.com
Children’s mental health issues have increased, insurance claims suggest
September 12, 2022 | cnbc.com
This little-known senior health care stock can surge more than 60%, Goldman Sachs says
September 9, 2022 | msn.com
I wouldn’t spend money on microbiome skincare products. The science isn’t there | Opinion
September 9, 2022 | markets.businessinsider.com
$11.3 million NIH Superfund award to address environmental health issues caused by VOCs
September 9, 2022 | wsj.com
Affordable Care Act Health-Plan Premiums Set to Rise
September 7, 2022 | apnews.com
Biophytis Announces Very Promising Top Line Results of its Phase 2-3 COVA Clinical Study in COVID-19-Related Respiratory Failure
September 2, 2022 | benzinga.com
AfterShip Announces SOC 2 Compliance, Taking "Enterprise Ready" to the Next Level
August 30, 2022 | reuters.com
HSAQ.OQ - | Stock Price & Latest News | Reuters
August 21, 2022 | duluthnewstribune.com
Pro/Con: CHIPS and Science Act a path to inefficiency, waste, political dysfunction
August 17, 2022 | msn.com
Here's How the Inflation Reduction Act Will Lower the Cost of Health Care
August 17, 2022 | news.yahoo.com
Democrats' sweeping health and climate package is now law
See More Headlines
Receive HSAQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health Sciences Acquisitions Co. 2 and its competitors with MarketBeat's FREE daily newsletter.

HSAQ Company Calendar

Today
9/27/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HSAQ
CUSIP
N/A
CIK
1814114
Web
N/A
Phone
N/A
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-380,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-2.38%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.17
Quick Ratio
0.61

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.62) per share
Price / Book
-12.73

Miscellaneous

Outstanding Shares
11,212,000
Free Float
8,757,000
Market Cap
$88.46 million
Optionable
Not Optionable
Beta
0.09
Ten Starter Stocks For Beginners to Buy Now Cover
Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Dr. Roderick Tze Ian Wong M.D. (Age 46)
    Pres, CEO & Chairman
  • Dr. Naveen Yalamanchi M.D. (Age 46)
    Exec. VP, CFO & Director
  • Ms. Alice Lee J.D. (Age 52)
    VP of Operations, Sec. & Treasurer
  • Ms. Stephanie A. Sirota (Age 47)
    VP of Corp. Strategy & Corp. Communications

Key Competitors

View All Competitors

Insiders

View All Insider Transactions













HSAQ Stock - Frequently Asked Questions

How have HSAQ shares performed in 2023?

Health Sciences Acquisitions Co. 2's stock was trading at $9.98 at the start of the year. Since then, HSAQ stock has decreased by 20.9% and is now trading at $7.89.
View the best growth stocks for 2023 here.

What other stocks do shareholders of Health Sciences Acquisitions Co. 2 own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Health Sciences Acquisitions Co. 2 investors own include Harbor Custom Development (HCDI), Gores Holdings V (GRSVU), FS Development (FSDC), Freeline Therapeutics (FRLN), Duck Creek Technologies (DCT), CureVac (CVAC), Checkmate Pharmaceuticals (CMPI), Burlington Stores (BURL), BigCommerce (BIGC) and KE (BEKE).

When did Health Sciences Acquisitions Co. 2 IPO?

(HSAQ) raised $139 million in an IPO on Tuesday, August 4th 2020. The company issued 13,900,000 shares at a price of $10.00 per share. Chardan and Barclays acted as the underwriters for the IPO.

What is Health Sciences Acquisitions Co. 2's stock symbol?

Health Sciences Acquisitions Co. 2 trades on the NASDAQ under the ticker symbol "HSAQ."

How do I buy shares of Health Sciences Acquisitions Co. 2?

Shares of HSAQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Health Sciences Acquisitions Co. 2's stock price today?

One share of HSAQ stock can currently be purchased for approximately $7.89.

How much money does Health Sciences Acquisitions Co. 2 make?

Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) has a market capitalization of $88.46 million.

This page (NASDAQ:HSAQ) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -